The Impact of Low-dose Gliclazide on the Incretin Effect and Indices of Beta-cell Function

AIMS/HYPOTHESIS: Studies in permanent neonatal diabetes suggest that sulphonylureas lower blood glucose without causing hypoglycemia, in part by augmenting the incretin effect. This mechanism has not previously been attributed to sulphonylureas in patients with type 2 diabetes (T2DM). We therefore a...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordiner, Ruth L M, Mari, Andrea, Tura, Andrea, Pearson, Ewan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Clinical Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692237/
https://www.ncbi.nlm.nih.gov/pubmed/33693776
http://dx.doi.org/10.1210/clinem/dgab151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692237/
https://www.ncbi.nlm.nih.gov/pubmed/33693776
http://dx.doi.org/10.1210/clinem/dgab151

Ejemplares similares